How Your Thyroid Controls Your Testosterone (Check This Before TRT)

Your thyroid makes testosterone possible. Not directly, not in the way most people think, but through a set of mechanisms that sit upstream of everything your testosterone system depends on, and if those mechanisms are broken, no amount of TRT is going to fix the actual problem.

Here is the full chain first, because without it the details will not land.

Your brain runs three hormonal systems through the same control center. A region called the hypothalamus sends signals down to the pituitary gland, the pituitary sends signals out to target glands, and those glands produce the hormones your body actually uses. The three systems are your thyroid axis, your testosterone axis, and your growth hormone axis. They share the same relay infrastructure, which means they are not running independently. What happens in one system changes what is possible in the others.

The thyroid axis starts when your hypothalamus releases something called TRH, which is the signal that tells your pituitary to pay attention to your thyroid. The pituitary responds by releasing TSH, which travels to your thyroid gland and tells it to produce hormones. Your thyroid puts out two of them. T4, called thyroxine, makes up about 80% of production. T3, called triiodothyronine, makes up the other 20%. T4 is the storage form and T3 is the active form, so T4 has to be converted into T3 before your body can use it. That conversion is done by enzymes called deiodinases, and they require selenium to function.

Think of it this way. T4 is raw material sitting in a warehouse and the deiodinase enzymes are the workers who process it into finished product. If you do not have enough workers, finished product runs low even though raw material is piling up. And there is a secondary pathway that makes this more complicated: T4 can also be converted into something called reverse T3, which is structurally similar to active T3 but biologically inactive. It occupies the same receptors without doing the same job. More on why that matters shortly.

The testosterone axis uses the exact same relay structure. Your hypothalamus releases GnRH, which tells your pituitary to release LH, and LH travels to your testes where it signals the Leydig cells to produce testosterone. Both axes run through the same hypothalamus and pituitary, and that shared infrastructure is exactly why thyroid status affects testosterone production.

The first mechanism is at the pituitary level. T3 controls how well your pituitary responds to the GnRH signal coming in from your hypothalamus. When thyroid function is low, the pituitary receives the GnRH signal but produces a weak LH response, so the relay station is passing the signal along at reduced strength. The downstream result is low testosterone paired with low or normal LH, a pattern called hypogonadotropic hypogonadism, where the problem is not the testes but the signaling that was never strong enough to reach them. A 2000 study by Donnelly and White looked at men with primary hypothyroidism and found that free testosterone nearly doubled, going from 161 to 315 pmol/L, after thyroxine replacement therapy. The pattern was hypogonadotropic throughout, meaning the testes were functional the whole time. They just were not getting an adequate signal.

The second mechanism is at the Leydig cell itself. These cells have thyroid hormone receptors on them, and T3 directly increases the number of LH receptors on their surface, making the cell more responsive to whatever signal it does receive. T3 also upregulates something called StAR protein, which stands for steroidogenic acute regulatory protein, and StAR protein is the rate limiting step in testosterone production because it transports cholesterol into the mitochondria where steroid synthesis actually begins. Maran and colleagues found that T3 induced a 260% increase in StAR protein expression in Leydig cells. Your thyroid hormone is controlling how much raw material gets delivered to the factory floor where testosterone is made.

The third mechanism involves something called SHBG, which stands for sex hormone binding globulin. Your liver produces SHBG in amounts that are partly regulated by thyroid status, and SHBG binds to testosterone and makes it biologically unavailable. This means your thyroid function changes the interpretation of your testosterone numbers, because the same total testosterone level means something different depending on how much of it is bound.

A 2022 conference abstract by Shrivastav and Saboo looked at 51 men with overt hypothyroidism and found that 50% had low testosterone at baseline. After levothyroxine normalized their thyroid function, 70% had their testosterone return to normal without any testosterone treatment. That is a small single-center dataset and a conference abstract rather than a peer reviewed paper, so the numbers carry less weight than the Donnelly study, but the direction is consistent with the mechanism.

The thyroid axis also sits upstream of your growth hormone response, which is where this becomes relevant for anyone using peptides. Your pituitary contains cells called somatotrophs that produce growth hormone, and these cells need adequate T3 to express the receptors that receive the growth hormone releasing signal. When thyroid function is low, the growth hormone response to stimulation is depressed, and T3 treatment restores it. The receptor that peptides like ipamorelin and MK-677 target, called the growth hormone secretagogue receptor, is also regulated by thyroid hormone. Kamegai and colleagues showed in 2001 that T3 increases expression of this receptor by extending its mRNA half-life from 8 hours to 15 hours in rat pituitary cells. That is an in vitro study using animal cells, so it is a mechanistic signal rather than confirmed human data, but the implication is that suboptimal thyroid function reduces the receptor density that peptides depend on to work.

Standard thyroid testing misses a significant portion of this. TSH alone tells you whether your hypothalamus and pituitary think the thyroid is keeping up, but it does not tell you whether T4 is being converted into active T3 or being shunted into reverse T3. Your TSH can look perfectly normal while your active T3 is low and your reverse T3 is elevated, a pattern called functional hypothyroidism that the standard panel will not catch. A full panel means TSH, free T3, free T4, and reverse T3. Alongside that, you want total testosterone, free testosterone, LH to determine whether any deficit is primary or secondary, and SHBG for context.

If the bloodwork shows suboptimal conversion rather than true hypothyroidism, there are nutritional levers worth checking before reaching for medication. Selenium at 200 micrograms per day supports deiodinase function, and research has directly linked selenium deficiency to an elevated T4 to T3 ratio, meaning the raw material is present but conversion is impaired. Do not exceed 400 micrograms. Zinc at 30 milligrams daily supports both TRH synthesis and thyroid hormone receptor function. Iron is a component of thyroid peroxidase, the enzyme your thyroid needs to produce T4 and T3 to begin with, and iron deficiency reduced thyroid peroxidase activity by 33 to 56% in animal research. Ferritin is worth checking. Iodine is the structural building block of both thyroid hormones, but excess iodine can worsen autoimmune thyroid conditions, so supplementing without confirmed deficiency creates risk.

Chronic stress is where the reverse T3 problem becomes most relevant in practice. Elevated cortisol activates the type 3 deiodinase enzyme that converts T4 into reverse T3 rather than active T3, and this shift happens within hours of acute stress exposure. The result is functional hypothyroidism with normal TSH, where your system appears fine on paper but your active thyroid hormone is being diverted into an inert form. This is not a stress management talking point. It is a specific enzymatic mechanism with direct downstream effects on testosterone and growth hormone response.

When the deficit is true hypothyroidism, Hashimoto's thyroiditis, elevated TSH with low T4 and T3, selenium and zinc will not resolve it. That requires levothyroxine under medical supervision, and over-replacement carries real risks including bone loss, atrial fibrillation, and anxiety, so this is not something to self-manage.

The sequence matters more than any individual piece of it. You would not wire the electrical in a building before you pour the foundation. If the thyroid axis is off, the testosterone axis and growth hormone axis are working against a broken substrate. Fixing the substrate first is not an alternative to treatment. It is what makes any treatment actually work.

---

References

1. Donnelly P, White C. 2000. Testicular dysfunction in men with primary hypothyroidism; reversal of hypogonadotrophic hypogonadism with replacement thyroxine. Clinical Endocrinology, 522:197-201. Free testosterone nearly doubled 161 to 315 pmol/L after thyroxine replacement in hypothyroid men. Source
2. Shrivastav A, Saboo B. 2022. Effect of levothyroxine replacement therapy on testosterone, LH, FSH levels in men with overt hypothyroidism. ECE2022 Conference Abstract, Endocrine Abstracts, 81, P730. 70% of hypogonadal hypothyroid patients had testosterone normalize after levothyroxine. Conference abstract, N=51. Source
3. Maran RR, et al. 2000. Assessment of mechanisms of thyroid hormone action in mouse Leydig cells. Endocrinology, 14112:4468-4477. T3 increases LH receptor numbers, StAR protein 260% increase, and steroidogenic enzyme expression in Leydig cells. Source
4. Kamegai J, et al. 2001. Thyroid hormones regulate pituitary growth hormone secretagogue receptor gene expression. Journal of Neuroendocrinology, 133:275-278. T3 increased GHS-R mRNA by extending half-life from 8h to 15h in rat pituitary cells. Source
5. Miki N, et al. 1989. Effects of hypothyroidism, T3 and glucocorticoids on GH responses to GHRH. Journal of Endocrinology, 122:585-591. Hypothyroidism depressed growth hormone response to GHRH; T3 treatment restored it. Source
6. Winther KH, et al. 2020. Thyroid function in patients with selenium deficiency exhibits high free T4 to T3 ratio. BMC Endocrine Disorders. Selenium deficiency directly associated with impaired T4 to T3 conversion. Source
7. Hess SY, et al. 2002. Iron deficiency anemia reduces thyroid peroxidase activity in rats. Journal of Nutrition, 1327:1951-1955. Iron deficiency reduced TPO activity by 33-56%. Source
8. Chopra IJ, et al. 1975. Opposite effects of dexamethasone on serum concentrations of reverse T3 and T3. Journal of Clinical Endocrinology and Metabolism. Cortisol shifts T4 metabolism toward reverse T3 within hours. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness